Home > Services > Clinical Research Studies > Clinical Trials Details
<< Back to Results
The purpose of this study is to compare overall survival in newly diagnosed metastatic prostate cancer patients randomly assigned to androgen deprivation therapy (ADT) + TAK-700 versus ADT + bicalutamide.
Essentia Health Duluth
For more information about a financial conflict of interest (FCOI) or to review the Essentia Health FCOI policy, click here.